Live Price
Live Volume
Chart Volume 0
Volume 0
5 secRocket Pharmaceuticals Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
-0.06(-1.79%)
| Open | $3.35 |
|---|---|
| Close | $3.29 |
| Low | $3.29 |
| Low Change | -0.06 (-1.79%) |
| High | $3.38 |
| High Change | +0.03 (+0.90%) |
| Range | $0.09 |
| Volume | 196.685K |
| Dollar Volume | $647.09K |
Regular Trading Hours Yesterday
-0.18(-4.97%)
| Open | $3.52 |
|---|---|
| Close | $3.35 |
| Low | $3.25 |
| Low Change | -0.27 (-7.67%) |
| High | $3.52 |
| High Change | +0.00 (+0.00%) |
| Range | $0.27 |
| Volume | 1.375M |
| Dollar Volume | $4.60M |
Premarket Yesterday
-0.02(-0.57%)
| Open | $3.51 |
|---|---|
| Close | $3.49 |
| Low | $3.49 |
| Low Change | -0.02 (-0.57%) |
| High | $3.58 |
| High Change | +0.07 (+1.99%) |
| Range | $0.09 |
| Volume | 1.139K |
| Dollar Volume | $3.98K |
Rocket Pharmaceuticals News
1 month agoinvesting.comWhy is Rocket Pharmaceuticals stock volatile today?
- 6 months agoinvesting.com
Rocket Pharmaceuticals, Argan jump premarket; Two Harbors inches down
6 months agobloomberg.comUS Premarket Movers: Argan, Rocket Pharmaceuticals, Unity
- 6 months agoinvesting.com
Rocket Pharmaceuticals stock gains on FDA gene therapy approval
Rocket Pharmaceuticals Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Rocket Pharmaceuticals Moving Averages
| 5 Day Moving Average (SMA5) | $3.61 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.70 |
| 20 Day Moving Average (SMA20) | $3.62 |
| 50 Day Moving Average (SMA50) | $3.57 |
| 100 Day Moving Average (SMA100) | $3.40 |
| 200 Day Moving Average (SMA200) | $3.59 |
Rocket Pharmaceuticals Statistics
| Average Volume (30 Days) | 1.43M |
|---|---|
| P/E Ratio (Current) | -21.75 |
| EPS (Current) | -$0.16 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$170.39M |
| Cash Ratio | 7.17 |
| Current Ratio | 9.24 |
| Quick Ratio | 9.24 |
| Debt to Equity | 0.06 |
| Enterprise Value | $178.78M |
| EV to EBITDA | -0.97 |
| EV to Sales | — |
| Price to Book | 1.04 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.04% |
| Return on Equity | -0.05% |
Rocket Pharmaceuticals Stock Splits
There have been no stock splits for Rocket Pharmaceuticals (RCKT).
Rocket Pharmaceuticals Dividends
There have been no dividends for Rocket Pharmaceuticals (RCKT).